Constellation Alpha Capital Corp.
Completed 2019-08-29- CIK 1651944
- CNAC
- Now DMTK
- IPO 2017-06-21
- $12.4M trust
- 497 filings
Successfully merged with DermTech Operations, Inc. • Now trading as DMTK
- IPO Size
- $144M
- raised at the IPO
- Trust
- $12.4M
- as of 2019-06-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2017
- year it listed
Filings, by quarter
497 filings over 44 quarters; violet bars carry a milestone
- 15 Q3: 1 filing
- 15 Q4: 3 filings
- 16 Q1: 0 filings
- 16 Q2: 0 filings
- 16 Q3: 0 filings
- 16 Q4: 0 filings
- 17 Q1: 0 filings
- 17 Q2: 23 filings
- 17 Q3: 3 filings
- 17 Q4: 1 filing
- 18 Q1: 6 filings
- 18 Q2: 1 filing
- 18 Q3: 4 filings
- 18 Q4: 3 filings
- 19 Q1: 10 filings
- 19 Q2: 6 filings
- 19 Q3: 51 filings
- 19 Q4: 11 filings
- 20 Q1: 52 filings
- 20 Q2: 42 filings
- 20 Q3: 23 filings
- 20 Q4: 18 filings
- 21 Q1: 26 filings
- 21 Q2: 30 filings
- 21 Q3: 16 filings
- 21 Q4: 11 filings
- 22 Q1: 22 filings
- 22 Q2: 18 filings
- 22 Q3: 20 filings
- 22 Q4: 10 filings
- 23 Q1: 17 filings
- 23 Q2: 26 filings
- 23 Q3: 12 filings
- 23 Q4: 6 filings
- 24 Q1: 10 filings
- 24 Q2: 13 filings
- 24 Q3: 1 filing
- 24 Q4: 0 filings
- 25 Q1: 0 filings
- 25 Q2: 0 filings
- 25 Q3: 0 filings
- 25 Q4: 0 filings
- 26 Q1: 0 filings
- 26 Q2: 1 filing
- S-1 filed 15 Q3
- IPO 17 Q2
- Completed 19 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Constellation Alpha Capital Corp. is a blank-check company seeking an initial business combination. It intends to focus on healthcare services and manufacturing businesses in India, while retaining the ability to pursue targets outside those industries.
Investment Focus
Healthcare, Manufacturing
Geographic Focus
India
Key Information
As the filings state it
- IPO Date
- 2017-06-21
- PIPE
- $24M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2019-08-29
- Merger Target
- DermTech Operations, Inc.
- SPAC Ticker
- CNAC
- Merged Ticker
- DMTK
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Chairman and CEO Rajiv Shukla, whose background includes healthcare investing, operating restructurings, and senior roles at Pfizer and Indian companies. CFO Craig Pollak has experience in investment strategies and raising institutional and private capital. Director nominees John Alexander, Alan Rosling, and Kewal Handa bring government, corporate operating, board, healthcare, and investment experience.